Detalhe da pesquisa
1.
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Breast Cancer Res
; 24(1): 71, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307826
2.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875670
3.
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Oncologist
; 24(6): e232-e240, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413667
4.
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
Breast Cancer Res Treat
; 163(3): 587-594, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28353061
5.
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.
Future Oncol
; 12(22): 2589-2602, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27443691
6.
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.
Future Oncol
; 11(3): 431-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25675124
7.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Breast J
; 26(9): 1857-1859, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436244
8.
Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
Oncotarget
; 15: 134-141, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386807
9.
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Breast
; 75: 103725, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615483
10.
Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.
Future Oncol
; 9(12): 1841-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24295414
11.
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland.
J Cancer Surviv
; 17(6): 1847-1858, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689003
12.
Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.
Cancer Metastasis Rev
; 29(2): 339-50, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20405170
13.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Clin Cancer Res
; 27(12): 3443-3455, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785482
14.
Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer.
Breast J
; 16(1): 66-72, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-19889170
15.
Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors.
Biosensors (Basel)
; 10(9)2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847008
16.
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).
Breast
; 53: 18-22, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540553
17.
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.
Breast Care (Basel)
; 15(1): 30-37, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32231495
18.
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Int J Cancer
; 124(1): 130-9, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18839429
19.
Pharmacotherapeutic options for patients with refractory breast cancer.
Expert Opin Pharmacother
; 20(7): 851-861, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30730767
20.
Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
Anticancer Res
; 28(2B): 1429-31, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18505091